Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Heart Disease Clinical Trials

A listing of Heart Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (2314) clinical trials

People with heart failure are asked to participate in a research study being conducted by Montefiore Medical Center. The MANAGE-HF study intends to evaluate whether proper clinical integration of HeartLogic, a remote monitoring diagnostic feature in Boston Scientific ICDs and CRT-Ds, can reduce heart failure hospitalization or other heart failure ...

Phase N/A

Cardiology/Vascular Diseases

Phase N/A

A global registry to study the demographics, socioeconomic and clinical factors, etiologies, pathophysiology, management, barriers to care, and outcomes of heart failure patients.

Phase N/A

A research study is evaluating the effects of an investigational study medication for heart failure in patients with iron deficiency.

Phase N/A

To evaluate the safety and efficacy of a once daily oral medication compared to a placebo, in patients with chronic Heart Failure with preserved Ejection Fraction.

Phase

To evaluate the effect of treatment with omecamtiv mecarbil (OM) compared with placebo on the time to cardiovascular (CV) death or first HF (Heart Failure) event, whichever occurs first, in subjects with chronic HF with reduced ejection fraction (HFrEF) receiving standard of care (SoC) therapy.

Phase N/A

To evaluate the efficacy of the oral soluble guanylate cyclase (sGC) stimulator MK-1242 (vericiguat) in comparison to placebo on a background of standard of care in increasing the time to first occurrence of the composite of CV death or HF hospitalization in subjects with HFrEF.

Phase N/A

Primary Objective: To evaluate whether long-term treatment with bempedoic acid 180 mg/day versus placebo reduces the risk of major adverse cardiovascular events (MACE) in patients with, or at high risk for, cardiovascular disease (CVD) who are statin intolerant. This will be assessed with a composite primary efficacy endpoint that includes ...

Phase

The primary endpoint of this study is the time to first  occurrence of any component of the composite endpoint, as adjudicated by the Clinical  Endpoint Committee (CEC). Components of the primary endpoint are:               Cardiovascular (CV) death      Resuscitated cardiac arrest    Non-­fatal MI         Non-­fatal stroke 

Phase

Don't wait, participate! A clinical trial for heart failure is now enrolling. Play an active role in your health care and contact us to see if you qualify to participate in this trial.

Phase